載入...
Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles
The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM the...
Na minha lista:
| 發表在: | J Neurooncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4498963/ https://ncbi.nlm.nih.gov/pubmed/25981803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1807-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|